March 5, 2007 Here’s an interesting new inhaler that provides metered dose inhaler (MDI) users with breath-activated delivery and dose-counting capabilities. From Accentia Biopharmaceuticals, the MD Turbo offers significant advantages for the users of many of the 40 million MDIs prescribed each year in the United States alone. Studies show that many patients using traditional press-and-breathe pMDIs (pressurized metered dose inhalers) to control asthma or Chronic Obstructive Pulmonary Disease (COPD), regardless of age or MDI experience, cannot successfully coordinate the press-and-breathe action necessary for drug delivery to the lungs. More than 70% of MDI users do not know the number of doses remaining in their inhalers at a given time.
An intelligent metered dose inhaler (MDI)
About the Author
Mike grew up thinking he would become a mathematician, accidentally started motorcycle racing, got a job writing road tests for a motorcycle magazine while at university, and became a writer. As a travelling photojournalist during his early career, his work was published in a dozen languages across 20+ countries. He went on to edit or manage over 50 print publications, with target audiences ranging from pensioners to plumbers, many different sports, many car and motorcycle magazines, with many more in the fields of communication - narrow subject magazines on topics such as advertising, marketing, visual communications, design, presentation and direct marketing. Then came the internet and Mike managed internet projects for Australia's largest multimedia company, Telstra.com.au (Australia's largest Telco), Seek.com.au (Australia's largest employment site), top100.com.au, hitwise.com, and a dozen other internet start-ups before founding Gizmag in 2002. Now he writes and thinks.All articles by Mike Hanlon